A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases

Administered By

Awarded By

Contributors

Start/End

  • October 15, 2016 - November 30, 2019